Nitrogen-containing bicyclic compound, preparation method and uses thereof

A technology for compounds and heterobicycles, which can be applied in the directions of active ingredients of heterocyclic compounds, preparation of sugar derivatives, chemical instruments and methods, etc., and can solve problems such as drug resistance and transformation.

Inactive Publication Date: 2018-10-16
OCEAN UNIV OF CHINA
View PDF12 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example: the thymidine kinase gene of HSV has a mutation, which cannot convert acyclovir and ganciclovir into effective components in cells, so it is resistant to these drugs; influenza A virus Mutations in the M2 protein gene of HIV will lead to drug resistance to amantadine or rimantadine; HIV reverse transcriptase or protease gene mutations are also the main cause of drug resistance; HCV non-structural 5A and envelope Genetic variation in gene 2-glycoprotein confers HCV resistance to interferon

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nitrogen-containing bicyclic compound, preparation method and uses thereof
  • Nitrogen-containing bicyclic compound, preparation method and uses thereof
  • Nitrogen-containing bicyclic compound, preparation method and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0171] Example 1. 3-methoxy-1-pentyl-4-(2-pyridyl)-1,6-naphthyridine-2 (1 H )-ketone

[0172]

[0173] Step 1) Under nitrogen protection, 3-(4-aminopyridine)-2-pyridinemethanone (2 mmol), methoxyacetyl chloride (3.8 mmol) and N, N-diisopropylethylamine (8 mmol) was dissolved in dichloromethane (5 mL) and reacted at room temperature for 3 hours. After pointing the plate, it was found that the reaction of the raw materials was complete. The reaction solution was diluted with water and extracted with ethyl acetate. After the organic phase was decompressed to remove the solvent, the residue was purified by silica gel column chromatography to obtain 3-(4-methoxyacetamido)-2-pyridine ketone.

[0174] Step 2) Under nitrogen protection, 3-(4-methoxyacetamido)-2-pyridinemethanone (1.0 mmol) was dissolved in tetrahydrofuran (10 mL), and t-BuOK (10 mmol) was added to react at room temperature 5 Hour. The reaction solution was extracted with saturated ammonium chloride solution and...

Embodiment 2

[0178] Example 2. 1-cyclopentyl-3-methoxy-4-(4-methoxyphenyl)-7-propionyl-1,6-naphthyridine-2(1 H )-ketone

[0179]

[0180] Step 1) Under nitrogen protection, 1-(4-amino-5-(4-methoxybenzoyl)-pyridin-2-propyl-1-one (2 mmol), methoxyacetyl chloride ( 3.8 mmol) and N,N-diisopropylethylamine (8 mmol) were dissolved in dichloromethane (5mL), and reacted at room temperature for 3 hours. The reaction of the raw materials was found to be complete by spotting the plate, and the reaction solution was diluted with water and extracted with ethyl acetate. After removing the solvent from the organic phase under reduced pressure, the residue was purified by silica gel column chromatography to obtain 1-(4-methoxyacetamido-5-(4-methoxybenzoyl)-pyridine-2-propyl-1- ketone.

[0181] Step 2) Under nitrogen protection, 1-(4-methoxyacetamido-5-(4-methoxybenzoyl)-pyridin-2-propyl-1-one (1.0 mmol) was dissolved in THF ( 10 mL), added t-BuOK (10 mmol) and reacted at room temperature for 5 hours...

Embodiment 3

[0185] Example 3. N,N-dimethylglycine-3-(3-methoxy 4-(3-methoxyphenyl)-2-oxoquinoline-1(2 H )-yl)propyl ester

[0186]

[0187] Step 1) 3-methoxy-4-(3-methoxyphenyl)quinoline-2(1 H The synthetic method of )-ketone is with reference to embodiment 1 and 2.

[0188] Step 2) Under nitrogen protection, CuI (1 mmol), Cs 2 CO 3 (20 mmol) and ethyl 2-oxocyclohexylcarboxylate (2 mmol) were added into DMSO (10 mL), and stirred at room temperature for 30 min. 3-methoxy-4-(3-methoxyphenyl)quinoline-2(1 H )-ketone (10 mmol) and 3-bromo-N,N-dimethylglycine propyl ester (10 mmol) in DMSO (12 mL) were added by injection. Heat to 100°C overnight. Cool to room temperature, filter, add water (50 mL) and dichloromethane (50 mL×3), collect the organic phase, evaporate the solvent under reduced pressure, and purify the crude product by column chromatography to obtain N,N-dimethylglycine- 3-(3-methoxy 4-(3-methoxyphenyl)-2-oxoquinoline-1(2 H )-yl)propyl ester.

[0189] ESI-MS (m / z): 425....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a nitrogen-containing bicyclic compound, a preparation method and uses thereof, and relates to an alkaloid compound, or a tautomer, a stereoisomer, a racemate, the non-equal mixture of enantiomers, a geometric isomer, a solvate, a pharmaceutically acceptable salt or a prodrug thereof, and a pharmaceutical composition containing the compound. The invention further discloses uses of the compounds and the pharmaceutical composition thereof as drugs, especially as antiviral drugs.

Description

technical field [0001] The present invention belongs to the field of medicine, and specifically relates to a nitrogen-containing bicyclic compound, its pharmaceutical composition and its use as a medicine, especially as an antiviral medicine. Background technique [0002] Viruses can be simply divided into non-enveloped viruses and enveloped viruses according to whether their shells are wrapped with lipid-rich membranes. Non-enveloped viruses mainly enter infected cells through pinocytosis mediated by clathrin; the invasion of enveloped viruses is mainly the fusion process of the viral envelope and the host cell membrane. At present, the research and development of antiviral agents are mainly designed based on two aspects, one is from the level of virus infection, and the other is from the level of host cell defense. Most antiviral drugs currently on the market are based on the virus itself, that is, the receptor for the action is the virus itself. Interferon (IFN) was the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D215/22C07D215/227C07D215/26C07D215/40C07D215/54C07D215/58C07D401/04C07D401/10C07D401/14C07D405/14C07D417/04C07D417/14C07D471/04C07H1/00C07H19/04C07H19/23A61K31/5377A61K31/496A61K31/4704A61K31/4709A61K31/4375A61K31/444A61K31/53A61K31/497A61K31/506A61K31/706A61K31/7064A61K31/541A61K31/4545A61P31/22A61P31/14A61P31/18A61P31/20A61P11/00A61P29/00A61P1/02A61P27/02A61P25/00A61P37/02
CPCC07D215/22C07D215/227C07D215/26C07D215/40C07D215/54C07D215/58C07D401/04C07D401/10C07D401/14C07D405/14C07D417/04C07D417/14C07D471/04C07H1/00C07H19/04C07H19/23
Inventor邵长伦牟晓凤魏美燕姜瑶瑶
OwnerOCEAN UNIV OF CHINA